FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2520007955> ?p ?o ?g. }

• W2520007955 endingPage "534" @default.
• W2520007955 startingPage "528" @default.
• W2520007955 abstract "Oritavancin is a lipoglycopeptide antibiotic with bactericidal activity against Gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA). The phase 3 studies SOLO I and SOLO II demonstrated comparable efficacy and safety of a single dose of oritavancin compared with 7–10 days of twice-daily vancomycin in adults with acute bacterial skin and skin-structure infections (ABSSSIs). The present analysis assessed clinical responses by pathogen at 48–72 h and at study days 14–24 in SOLO patients within the pooled data set. Of the 1959 patients in the pooled SOLO studies, 1067 had at least one baseline Gram-positive pathogen and 405 had MRSA. Clinical response rates were similar for oritavancin- and vancomycin-treated patients by pathogen, including Staphylococcus aureus with or without the Panton–Valentine leukocidin (pvl) gene and from different clonal complexes, and were similar for pathogens within each treatment group. Oritavancin exhibited potent in vitro activity against all baseline pathogens, with MIC90 values (minimum inhibitory concentration required to inhibit 90% of the isolates) of 0.12 µg/mL for Staphylococcus aureus, 0.25 µg/mL for Streptococcus pyogenes and 0.06 µg/mL for Enterococcus faecalis. Whereas both oritavancin and vancomycin achieved similarly high rates of clinical response by pathogen, including methicillin-susceptible and -resistant Staphylococcus aureus, oritavancin provides a single-dose alternative to 7–10 days of twice-daily vancomycin to treat ABSSSIs." @default.
• W2520007955 created "2016-09-23" @default.
• W2520007955 creator A5010952579 @default.
• W2520007955 creator A5016471584 @default.
• W2520007955 creator A5024284785 @default.
• W2520007955 creator A5030449858 @default.
• W2520007955 creator A5033269948 @default.
• W2520007955 creator A5038009031 @default.
• W2520007955 creator A5044485195 @default.
• W2520007955 creator A5059997287 @default.
• W2520007955 creator A5060779744 @default.
• W2520007955 creator A5062306774 @default.
• W2520007955 creator A5063290824 @default.
• W2520007955 creator A5071196571 @default.
• W2520007955 creator A5090385625 @default.
• W2520007955 date "2016-11-01" @default.
• W2520007955 modified "2023-10-14" @default.
• W2520007955 title "Pooled analysis of single-dose oritavancin in the treatment of acute bacterial skin and skin-structure infections caused by Gram-positive pathogens, including a large patient subset with methicillin-resistant Staphylococcus aureus" @default.
• W2520007955 cites W1182479101 @default.
• W2520007955 cites W1964024657 @default.
• W2520007955 cites W1965068704 @default.
• W2520007955 cites W1970780793 @default.
• W2520007955 cites W1988722434 @default.
• W2520007955 cites W1993975311 @default.
• W2520007955 cites W2001833616 @default.
• W2520007955 cites W2021480243 @default.
• W2520007955 cites W2022858682 @default.
• W2520007955 cites W2026104361 @default.
• W2520007955 cites W2072564389 @default.
• W2520007955 cites W2085409853 @default.
• W2520007955 cites W2092084708 @default.
• W2520007955 cites W2092645865 @default.
• W2520007955 cites W2100126589 @default.
• W2520007955 cites W2101496201 @default.
• W2520007955 cites W2104411795 @default.
• W2520007955 cites W2113886878 @default.
• W2520007955 cites W2116814997 @default.
• W2520007955 cites W2119300753 @default.
• W2520007955 cites W2125019773 @default.
• W2520007955 cites W2138860487 @default.
• W2520007955 cites W2144069506 @default.
• W2520007955 cites W2148873314 @default.
• W2520007955 cites W2155065994 @default.
• W2520007955 cites W2155965882 @default.
• W2520007955 cites W2157885066 @default.
• W2520007955 cites W2161621663 @default.
• W2520007955 cites W2218932146 @default.
• W2520007955 cites W2220281049 @default.
• W2520007955 cites W4214754383 @default.
• W2520007955 doi "https://doi.org/10.1016/j.ijantimicag.2016.07.019" @default.
• W2520007955 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27665522" @default.
• W2520007955 hasPublicationYear "2016" @default.
• W2520007955 type Work @default.
• W2520007955 sameAs 2520007955 @default.
• W2520007955 citedByCount "28" @default.
• W2520007955 countsByYear W25200079552017 @default.
• W2520007955 countsByYear W25200079552018 @default.
• W2520007955 countsByYear W25200079552019 @default.
• W2520007955 countsByYear W25200079552020 @default.
• W2520007955 countsByYear W25200079552021 @default.
• W2520007955 countsByYear W25200079552022 @default.
• W2520007955 countsByYear W25200079552023 @default.
• W2520007955 crossrefType "journal-article" @default.
• W2520007955 hasAuthorship W2520007955A5010952579 @default.
• W2520007955 hasAuthorship W2520007955A5016471584 @default.
• W2520007955 hasAuthorship W2520007955A5024284785 @default.
• W2520007955 hasAuthorship W2520007955A5030449858 @default.
• W2520007955 hasAuthorship W2520007955A5033269948 @default.
• W2520007955 hasAuthorship W2520007955A5038009031 @default.
• W2520007955 hasAuthorship W2520007955A5044485195 @default.
• W2520007955 hasAuthorship W2520007955A5059997287 @default.
• W2520007955 hasAuthorship W2520007955A5060779744 @default.
• W2520007955 hasAuthorship W2520007955A5062306774 @default.
• W2520007955 hasAuthorship W2520007955A5063290824 @default.
• W2520007955 hasAuthorship W2520007955A5071196571 @default.
• W2520007955 hasAuthorship W2520007955A5090385625 @default.
• W2520007955 hasConcept C2775983603 @default.
• W2520007955 hasConcept C2776460866 @default.
• W2520007955 hasConcept C2777052132 @default.
• W2520007955 hasConcept C2777334864 @default.
• W2520007955 hasConcept C2777859817 @default.
• W2520007955 hasConcept C2778980435 @default.
• W2520007955 hasConcept C2779489039 @default.
• W2520007955 hasConcept C2779895986 @default.
• W2520007955 hasConcept C501593827 @default.
• W2520007955 hasConcept C523546767 @default.
• W2520007955 hasConcept C54355233 @default.
• W2520007955 hasConcept C71924100 @default.
• W2520007955 hasConcept C86803240 @default.
• W2520007955 hasConcept C89423630 @default.
• W2520007955 hasConceptScore W2520007955C2775983603 @default.
• W2520007955 hasConceptScore W2520007955C2776460866 @default.
• W2520007955 hasConceptScore W2520007955C2777052132 @default.
• W2520007955 hasConceptScore W2520007955C2777334864 @default.
• W2520007955 hasConceptScore W2520007955C2777859817 @default.
• W2520007955 hasConceptScore W2520007955C2778980435 @default.
• W2520007955 hasConceptScore W2520007955C2779489039 @default.
• W2520007955 hasConceptScore W2520007955C2779895986 @default.

• next